Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.46 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
| ▸ | STAT6 | P42226 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29721865 | 0.94 | KDM4E (0.50) | KDM4ETSHRLMNACYP3A4ESR1 | |
| SCHEMBL680046 | 0.94 | KDM4E (0.50) | KDM4ETSHRLMNACYP3A4ESR1 | |
| Hydrochloric Acid SCHEMBL711904 | 0.92 | KDM4E (0.49) | KDM4ETSHRLMNACYP3A4ESR1 | |
| SCHEMBL11122315 | 0.92 | KDM4E (0.49) | KDM4ETSHRLMNACYP3A4ESR1 | |
| Formic Acid SCHEMBL28236591 | 0.87 | KDM4E (0.45) | KDM4ETSHRLMNACYP3A4ESR1 | |
| Pyrrole SCHEMBL28102266 | 0.84 | TSHR (0.43) | KDM4ETSHRLMNACYP3A4ESR1 | |
| Maleic Acid SCHEMBL27920212 | 0.84 | KDM4E (0.44) | KDM4ETSHRLMNACYP3A4ESR1 | |
| SCHEMBL9685375 | 0.82 | KDM4E (0.41) | KDM4ETSHRLMNACYP3A4ESR1 | |
| SCHEMBL12052657 | 0.81 | ALDH1A1 (0.49) | KDM4ETSHRLMNAALDH1A1NPC1 | |
| SCHEMBL245065 | 0.79 | NPC1 (0.46) | KDM4ETSHRLMNACYP3A4ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6028231-A | Process for preparing 2-methyl-4-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-but-2-en-1-ol | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-02-22 | — | — | US | claimed |
| EP-1957437-B1 | PROCESS FOR PRODUCING ALPHA,BETA-UNSATURATED ALDEHYDE COMPOUNDS | KAO CORP (JP) | 2017-05-03 | — | — | EP | disclosed |
| US-7732644-B2 | Process for producing α,β-unsaturated aldehyde compounds | KAO CORPORATION (JP) | 2010-06-08 | — | — | US | disclosed |
| US-20090171124-A1 | PROCESS FOR PRODUCING ALPHA, BETA-UNSATURATED ALDEHYDE COMPOUNDS | KAO CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| EP-1957437-A1 | PROCESS FOR PRODUCING ALPHA,BETA-UNSATURATED ALDEHYDE COMPOUNDS | Kao Corporation (JP) | 2008-08-20 | — | — | EP | disclosed |
| WO-2007063703-A1 | PROCESS FOR PRODUCING α,β-UNSATURATED ALDEHYDE COMPOUNDS | KAO CORPORATION (JP) | 2007-06-07 | — | — | WO | disclosed |
| US-7169749-B1 | Aldol condensation carried out in an inert organic solvent, and reduction of the corresponding unsaturated aldehydes in the presence of copper/zinc catalysts, the process being carried out continuously under isothermal conditions in a narrow temperature range | KAO CORPORATION (JP) | 2007-01-30 | — | — | US | disclosed |
| US-6028231-A | Process for preparing 2-methyl-4-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-but-2-en-1-ol | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090171124-A1 | PROCESS FOR PRODUCING ALPHA, BETA-UNSATURATED ALDEHYDE COMPOUNDS | ADH1C, ADH1A, ADH5 | KDM4E 4701/4885TSHR 4189/4885LMNA 425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.